论文信息 - Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma - 字舞流文

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma

E. Lipp | H. Friedman | A. Desjardins | G. Vlahović | J. Vredenburgh | J. Jackman | J. Herndon | M. Affronti | K. Peters | F. McSherry | Elwood C. Massey